Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

被引：29

作者：

Engert, A. ^{[1
]}

Eichenauer, D. A. ^{[1
]}

Dreyling, M. ^{[2
]}

机构：

[1] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany

[2] Univ Hosp Grosshadern, Dept Med 3, Munich, Germany

来源：

ANNALS OF ONCOLOGY | 2010年 / 21卷

关键词：

STEM-CELL TRANSPLANTATION; POSITRON-EMISSION-TOMOGRAPHY; 2; CYCLES; CHEMOTHERAPY; RADIOTHERAPY; PROGRESSION; DISEASE; RITUXIMAB; SUPERIOR; RELAPSE;

D O I：

10.1093/annonc/mdq181

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：v168 / v171

页数：4

共 17 条

[1]

Borchmann P, 2008, BLOOD, V112

[2] Revised response criteria for malignant lymphoma [J].

Cheson, Bruce D. ;

Pfistner, Beate ;

Juweid, Malik E. ;

Gascoyne, Randy D. ;

Specht, Lena ;

Horning, Sandra J. ;

Coiffier, Bertrand ;

Fisher, Richard I. ;

Hagenbeek, Anton ;

Zucca, Emanuele ;

Rosen, Steven T. ;

Stroobants, Sigrid ;

Lister, T. Andrew ;

Hoppe, Richard T. ;

Dreyling, Martin ;

Tobinai, Kensei ;

Vose, Julie M. ;

Connors, Joseph M. ;

Federico, Massimo ;

Diehl, Volker .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :579-586

[3] Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial [J].

Ekstrand, BC ;

Lucas, JB ;

Horwitz, SM ;

Fan, Z ;

Breslin, S ;

Hoppe, RT ;

Natkunam, Y ;

Bartlett, NL ;

Horning, SJ .

BLOOD, 2003, 101 (11) :4285-4289

[4] Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma:: Final results of the GHSG HD7 trial [J].

Engert, Andreas ;

Franklin, Jeremy ;

Eich, Hans Theodor ;

Brillant, Corinne ;

Sehlen, Susanne ;

Cartoni, Claudio ;

Herrmann, Richard ;

Pfreundschuh, Michael ;

Sieber, Markus ;

Tesch, Hans ;

Franke, Astrid ;

Koch, Peter ;

de Wit, Maike ;

Paulus, Ursula ;

Hasenclever, Dirk ;

Loeffler, Markus ;

Mueller, Rolf-Peter ;

Mueller-Hermelink, Hans Konrad ;

Duehmke, Eckhart ;

Diehl, Volker .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (23) :3495-3502

[5] Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease [J].

Ferme, Christophe ;

Eghbali, Houchingue ;

Meerwaldt, Jacobus H. ;

Rieux, Chantal ;

Bosq, Jacques ;

Berger, Francoise ;

Girinsky, Theodore ;

Brice, Pauline ;

van't Veer, Mars B. ;

Walewski, Jan A. ;

Lederlin, Pierre ;

Tirelli, Umberto ;

Carde, Patrice ;

Van den Neste, Eric ;

Gyan, Emmanuel ;

Monconduit, Mathieu ;

Divine, Marine ;

Raemaekers, John M. M. ;

Salles, Gilles ;

Noordijk, Evert M. ;

Creemers, Geert-Jan ;

Gabarre, Jean ;

Hagenbeek, Anton ;

Reman, Oumedaly ;

Blanc, Michel ;

Thomas, Jose ;

Vie, Brigitte ;

Kluin-Nelemans, Johanna C. ;

Viseu, Fernando ;

Baars, Joke W. ;

Poortmans, Philip ;

Lugtenburg, Pieternella J. ;

Carrie, Christian ;

Jaubert, Jerome ;

Henry-Amar, Michel .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (19) :1916-1927

[6] Early interim 2-[18F]Fluoro-2-Deoxy-D-Glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma:: A report from a joint Italian-Danish study [J].

Gallamini, Andrea ;

Hutchings, Martin ;

Rigacci, Luigi ;

Specht, Lena ;

Merli, Francesco ;

Hansen, Mads ;

Patti, Caterina ;

Loft, Annika ;

Di Raimondo, Francesco ;

D'Amore, Francesco ;

Biggi, Alberto ;

Vitolo, Umberto ;

Stelitano, Caterina ;

Sancetta, Rosario ;

Trentin, Livio ;

Luminari, Stefano ;

Iannitto, Emilio ;

Viviani, Simonetta ;

Pierri, Ivana ;

Levis, Alessandro .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) :3746-3752

[7] FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma [J].

Hutchings, M ;

Loft, A ;

Hansen, M ;

Pedersen, LM ;

Buhl, T ;

Jurlander, J ;

Buus, S ;

Keiding, S ;

D'Amore, F ;

Boesen, AM ;

Berthelsen, AK ;

Specht, L .

BLOOD, 2006, 107 (01) :52-59

[8] Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma:: A retrospective analysis from the German Hodgkin Lymphoma Study Group [J].

Josting, A ;

Nogová, L ;

Franklin, J ;

Glossmann, JP ;

Eich, HT ;

Sieber, M ;

Schober, T ;

Boettcher, HD ;

Schulz, U ;

Müller, RP ;

Diehl, V ;

Engert, A .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) :1522-1529

[9] Time-intensified dexamethasone/cisplatin/cytarabine:: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin's disease [J].

Josting, A ;

Rudolph, C ;

Reiser, M ;

Mapara, M ;

Sieber, M ;

Kirchner, HH ;

Dörken, B ;

Hossfeld, DK ;

Diehl, V ;

Engert, A .

ANNALS OF ONCOLOGY, 2002, 13 (10) :1628-1635

[10] Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma [J].

Kobe, Carsten ;

Dietlein, Markus ;

Franklin, Jeremy ;

Markova, Jana ;

Lohri, Andreas ;

Amthauer, Holger ;

Klutmann, Susanne ;

Knapp, Wolfram H. ;

Zijlstra, Josee M. ;

Bockisch, Andreas ;

Weckesser, Matthias ;

Lorenz, Reinhard ;

Schreckenberger, Mathias ;

Bares, Roland ;

Eich, Hans T. ;

Mueller, Rolf-Peter ;

Fuchs, Michael ;

Borchmann, Peter ;

Schicha, Harald ;

Diehl, Volker ;

Engert, Andreas .

BLOOD, 2008, 112 (10) :3989-3994

← 1 2 →